EchoPixel, the pioneer of True 3D, an interactive Virtual Reality software solution that assists healthcare professionals in detailed interpretation of medical images, both for diagnosis and surgical planning, has closed an $8.5 million Series A financing.
The financing round was led by new investor Intel Capital and included existing investors Aurus Capital, Runa Capital and Harris & Harris Group. Also participating were new investors LAM Research and Binomial. Proceeds from the Series A financing will be allocated towards expanding EchoPixel's Commercial, R&D and Regulatory organizations.
True 3D is being used in clinical and research settings around the world, including the University of California, San Francisco, Stanford, the Cleveland Clinic, the Lahey Clinic, and the Hershey Medical Center.
Making Medical Images More Exciting
"With its promise to make medical images more accessible to more clinicians and transform the ways doctors work and patients understand their unique anatomy, EchoPixel's True 3D has generated excitement in the medical community," said Sergio Aguirre, founder and Chief Executive Officer of EchoPixel.
"Intel Capital invests in pioneering technologies," said Wendell Brooks, senior vice president of Intel Corp. and president of Intel Capital. "We are excited to invest in EchoPixel and to see their technology transform patient care through the use of Augmented Reality."